• Profile
Close

COAST (Cisplatin ototoxicity attenuated by aspirin trial): A phase II double-blind, randomised controlled trial to establish if aspirin reduces cisplatin induced hearing-loss

European Journal of Cancer Dec 04, 2017

Crabb SJ, et al. - In view of the efficacy of aspirin in minimising gentamicin-induced ototoxicity, researchers here tested the hypothesis that aspirin could also reduce ototoxicity from cisplatin-based chemotherapy. They observed no protective effect of aspirin against cisplatin-related ototoxicity. Thereby suggesting distinct ototoxic mechanisms of cisplatin and gentamicin, or cisplatin-induced ototoxicity may be refractory to the aspirin regimen used here.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay